Connectus Wealth’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,932
Closed -$439K 450
2023
Q4
$439K Buy
1,932
+6
+0.3% +$1.26K 0.01% 417
2023
Q3
$387K Sell
1,926
-308
-14% -$65K 0.01% 407
2023
Q2
$463K Buy
2,234
+10
+0.4% +$1.94K 0.01% 355
2023
Q1
$439K Buy
+2,224
New +$458K 0.01% 351
2022
Q4
Sell
-2,316
Closed -$408K 478
2022
Q3
$408K Buy
2,316
+7
+0.3% +$1.43K 0.01% 426
2022
Q2
$465K Buy
2,309
+1
+0% +$213 0.01% 340
2022
Q1
$623K Sell
2,308
-345
-13% -$81.1K 0.02% 290
2021
Q4
$716K Buy
+2,653
New +$657K 0.03% 242

Other funds holding LH

Connectus Wealth's LH Position: Q1 2024 in Review

Connectus Wealth sold out of Labcorp (LH) in Q1 2024, closing a stake of 1,932 shares — an estimated $439K sold.

Connectus Wealth first reported a position in LH in Q4 2021 and held it in 8 quarters. The position peaked at $716K in Q4 2021. 927 funds tracked by Wall St. Rank hold LH as of Q1 2024.

  • Connectus Wealth reported no remaining Labcorp position as of Q1 2024 after selling out during the quarter.
  • Connectus Wealth sold 1,932 Labcorp shares in Q1 2024, an estimated $439K.
  • Connectus Wealth first reported a position in Labcorp in Q4 2021 and held it in 8 quarters.
  • Connectus Wealth's Labcorp position peaked at $716K in Q4 2021.
  • 927 funds tracked by Wall St. Rank held Labcorp as of Q1 2024.

Based on Connectus Wealth's 13F filing for Q1 2024, filed 14 May 2024.